Candidiasis
ICD-10 B37 is a billable code used to indicate a diagnosis of candidiasis.
Candidiasis is a fungal infection caused by yeasts of the genus Candida, with Candida albicans being the most common species implicated in human infections. This condition can manifest in various forms, including oropharyngeal candidiasis (thrush), esophageal candidiasis, vulvovaginal candidiasis, and invasive candidiasis, which can affect the bloodstream and internal organs. The infection typically occurs in immunocompromised individuals, such as those with HIV/AIDS, cancer patients undergoing chemotherapy, organ transplant recipients, and patients on long-term corticosteroid therapy. Symptoms may vary depending on the site of infection but often include itching, irritation, and discomfort in localized areas, as well as systemic symptoms in cases of invasive candidiasis. Diagnosis is primarily based on clinical evaluation and laboratory tests, including culture and sensitivity testing. Treatment usually involves antifungal medications, such as fluconazole, itraconazole, or amphotericin B, depending on the severity and location of the infection. Prompt diagnosis and treatment are crucial to prevent complications, especially in immunocompromised patients.
Detailed patient history, including immunocompromised status and previous infections.
Management of recurrent candidiasis in HIV-positive patients or those undergoing chemotherapy.
Ensure documentation reflects the severity and site of infection for accurate coding.
Clear documentation of symptoms, examination findings, and treatment plans for vulvovaginal candidiasis.
Diagnosis and treatment of recurrent vulvovaginal candidiasis in women.
Document any associated conditions, such as diabetes or antibiotic use, that may contribute to candidiasis.
Used to confirm diagnosis of candidiasis.
Document the source of the culture and any relevant clinical findings.
Infectious disease specialists should ensure cultures are obtained before starting antifungal therapy.
Common symptoms include itching, irritation, and discomfort in affected areas, white patches in the mouth or throat, and systemic symptoms in cases of invasive candidiasis.
Diagnosis is typically made through clinical evaluation and laboratory tests, including cultures and sensitivity testing to identify the specific Candida species.
Treatment options include antifungal medications such as fluconazole, itraconazole, and amphotericin B, depending on the severity and location of the infection.
